← Evidence map

TrialNutrients2026

School-Age Neurodevelopmental and Atopy Outcomes in Extremely Preterm Infants: Follow-Up from the Single Versus Triple-Strain Bifidobacterium Randomized Controlled Trial.

Gayatri Athalye-Jape et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

School-Age Neurodevelopmental and Atopy Outcomes in Extremely Preterm Infants: Follow-Up from the Single Versus Triple-Strain Bifidobacterium Randomized Controlled Trial. | Socratic